Amino Acid Disorders 3
The Amino Acid Disorders 3 session will be discussing NKH, Lysine metab (GA1 and PDE).
Commercial Supporter
This educational activity is supported by an educational grant from Ultragenyx.
Learning Objectives
- Comprehend the fundamental clinical and biochemical characteristics of urea cycle disorders.
- Differentiate and recognize the distinct clinical and biochemical features of each urea cycle disorder.
- Develop an understanding of the overall principles for managing urea cycle disorders.
- Understand the clinical and biochemical attributes specific to maple syrup urine disease (MSUD).
- Comprehend the management principles applied in cases of maple syrup urine disease (MSUD).
Medical Biochemical Genetics is hosted virtually via Zoom. Zoom details will be provided after registering for the course.
Guest Faculty
Nicholas Ah Mew, MD
Children's National Hospital
Disclosures
Nicholas Ah Mew, MD, speaker for this activity, is a consultant for ModernaTherapeutics, Jnana Therapeutics, iECURe, UncommonCures and Ultragenyx and a clinical trial principal investigator for Recordati Rare Disease.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Medical
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance